屈永平, 姚鸿超, 赵春源, 王鑫. 白细胞介素22在恶性肿瘤中的研究进展[J]. 中国肿瘤临床, 2014, 41(8): 542-544. DOI: 10.3969/j.issn.1000-8179.20132026
引用本文: 屈永平, 姚鸿超, 赵春源, 王鑫. 白细胞介素22在恶性肿瘤中的研究进展[J]. 中国肿瘤临床, 2014, 41(8): 542-544. DOI: 10.3969/j.issn.1000-8179.20132026
QU Yongping, YAO Hongchao, ZHAO Chunyuan, WANG Xin. Research progress in interleukin-22 treatment of malignant tumors[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 41(8): 542-544. DOI: 10.3969/j.issn.1000-8179.20132026
Citation: QU Yongping, YAO Hongchao, ZHAO Chunyuan, WANG Xin. Research progress in interleukin-22 treatment of malignant tumors[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 41(8): 542-544. DOI: 10.3969/j.issn.1000-8179.20132026

白细胞介素22在恶性肿瘤中的研究进展

Research progress in interleukin-22 treatment of malignant tumors

  • 摘要: 白细胞介素22(IL-22)是白细胞介素10家族中的一员,与IL-10具有相似的结构和免疫作用,主要由Th22、Th1、Th17细胞、固有淋巴细胞(ILCs)、γδT细胞和NKT细胞分泌。IL-22在自身免疫性疾病、恶性肿瘤和感染性疾病中发挥重要作用。有关IL-22细胞因子在各种恶性肿瘤中的作用机制,仍是目前研究的热点。研究IL-22在恶性肿瘤中的表达及作用机制,为恶性肿瘤的治疗和预防提供了新的思路。本文从IL-22的发现、结构特点及其在恶性肿瘤中的作用进行综述。

     

    Abstract: Interleukin-22 (IL-22) is a member of the IL-10 family, which exhibits a similar structure and immune function with IL-10. IL-22 is mainly secreted by Th22, Th1, and Th17 cells, innate lymphoid cells (ILCs), and γδT and NKT cells. IL-22 is mainly involved in autoimmune diseases, malignant tumors, and infective diseases. As such, studies have focused on the function of IL-22 cytokine in the pathogenesis of various malignant tumors. Studies revealing the expression and pathogenesis of IL-22 in malignant tumors possibly provide a new method to treat and prevent malignant tumors. In our study, the discovery, structural characteristics, and functions of IL-22 in malignant tumors are reviewed.

     

/

返回文章
返回